Morvan syndrome associated with CASPR2 and LGI1 antibodies in a child
Citation Manager Formats
Make Comment
See Comments
![Loading Loading](https://n.neurology.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
A 16-year-old boy presented with a 3-week history of back pain, insomnia, profuse sweating, and constipation following a respiratory infection. Physical examination revealed tachycardia, arterial hypertension, muscle weakness, and postural tremor. After hospital admission, he showed almost complete insomnia and massive hyperhidrosis, forcing him to change clothes every 15 minutes and drink up to 12 L/d. He deteriorated, with confusion, hallucination, and additional motor symptoms like fasciculations, areflexia, and muscle cramps/stiffness of both legs that prevented walking. His modified Rankin Scale (mRS) score was 4. Initial blood chemistry only revealed mild hyponatremia. Repeated neuroimaging and extended screening for infectious and neoplastic disease were unremarkable. Electroneurography revealed demyelinating peripheral neuropathy and EMG showed rare spontaneous discharges without the full picture of peripheral nerve hyperexcitability. Serum catecholamine levels were elevated and CSF analysis revealed high protein levels with normal cell count and without oligoclonal bands. Antineuronal antibody screening in serum detected antibodies against the voltage-gated potassium channel (VGKC) complex by radioimmunoassay (RIA, 283 pmol/L) and high titers (1:10,000) against contactin-associated protein 2 (CASPR2) by a commercial cell-based assay (CBA; indirect immunofluorescence on BIOCHIP-Mosaic, Euroimmun, Lübeck, Germany). As the CNS was strongly affected, we analyzed CSF reactivity with a tissue-based assay (TBA). CSF incubation on murine brain sections and subsequent visualization with fluorescent-labeled antihuman immunoglobulin G antibodies revealed a strong signal in the neuropil, mainly of hippocampus and cerebellum (figure, A–D). The CBA confirmed a low CSF anti-CASPR2 antibody titer (1:10) without intrathecal synthesis (table e-1, links.lww.com/WNL/A71, for full diagnostic results).
Footnotes
Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
- Received June 19, 2017.
- Accepted in final form October 10, 2017.
- Copyright © 2017 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
More Online
Dr. Jessica Ailani and Dr. Ailna Masters-Israilov
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Article
Immunoadsorption therapy in autoimmune encephalitidesMüjgan Dogan Onugoren, Kristin S. Golombeck, Corinna Bien et al.Neurology - Neuroimmunology Neuroinflammation, February 26, 2016 -
Views and Reviews
Encephalitis and antibodies to synaptic and neuronal cell surface proteinsEric Lancaster, Eugenia Martinez-Hernandez, Josep Dalmau et al.Neurology, July 11, 2011 -
Article
CASPR2 autoimmunity in children expanding to mild encephalopathy with hypertensionSteffen Syrbe, Georg M. Stettner, Julien Bally et al.Neurology, May 18, 2020 -
Research
CASPR2-Related Morvan SyndromeAutonomic, Polysomnographic, and Neuropsychological ObservationsPanda Sudha Swayang, Atchayaram Nalini, Veeramani Preethish-Kumar et al.Neurology: Clinical Practice, October 06, 2020